Lianjing Cao
Qingdao University(CN)Affiliated Hospital of Qingdao University(CN)
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, Pancreatic and Hepatic Oncology Research, Renin-Angiotensin System Studies, Cancer Mechanisms and Therapy, Lung Cancer Treatments and Mutations
Most-Cited Works
- → PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway(2018)60 cited
- → A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening(2022)49 cited
- → ATAD2 interacts with C/EBPβ to promote esophageal squamous cell carcinoma metastasis via TGF-β1/Smad3 signaling(2021)40 cited
- → Glycogenes in Oncofetal Chondroitin Sulfate Biosynthesis are Differently Expressed and Correlated With Immune Response in Placenta and Colorectal Cancer(2021)39 cited
- → Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer(2019)38 cited
- → Oral Microbiota Alteration and Roles in Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma(2023)38 cited
- → PD-L1 is a Prognostic Biomarker in Resected NSCLC Patients with Moderate/high Smoking History and Elevated Serum SCCA Level(2017)24 cited
- → Establishment and validation of a plasma oncofetal chondroitin sulfated proteoglycan for pan-cancer detection(2023)17 cited
- → PIM1 kinase promotes EMT-associated osimertinib resistance via regulating GSK3β signaling pathway in EGFR-mutant non-small cell lung cancer(2024)13 cited
- → A fecal-based test for the detection of advanced adenoma and colorectal cancer: a case-control and screening cohort study(2021)12 cited